ALK GBSC
About Us
News
Careers
Contact
Zgłaszanie działań niepożądanych
Fulltext search
Search
ACARIZAX® approved in Europe for treatment of young children
Link
https://www.globenewswire.com/news-release/2024/12/12/2996326/0/en/ACARIZAX-app…
Created date
Thu, 12/12/2024 - 12:00
Nasdaq ID
2996326
Last updated:
2024.12.12